8-isoprostaglandin-e2 and Osteoporosis

8-isoprostaglandin-e2 has been researched along with Osteoporosis* in 2 studies

Other Studies

2 other study(ies) available for 8-isoprostaglandin-e2 and Osteoporosis

ArticleYear
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
    The Journal of biological chemistry, 2002, Apr-19, Volume: 277, Issue:16

    Lipid oxidation products promote atherosclerosis and may also affect osteoporosis. We showed previously that oxidized lipids including 8-isoprostaglandin E2 (isoPGE2) inhibit osteoblastic differentiation of preosteoblasts. Since osteoporosis is mediated both by decreased osteoblastic bone formation and by increased osteoclastic bone resorption, we assessed whether oxidized lipids regulate the osteoclastic potential of marrow hematopoietic cells. Treatment of marrow-derived preosteoclasts with isoPGE2 enhanced osteoclastic differentiation as evidenced by increased tartrate-resistant acid phosphatase (TRAP) activity and multinucleation, which were inhibited by calcitonin, and increased numbers of resorption pits. The enhanced osteoclastic differentiation by isoPGE2 was observed whether preosteoclasts were in coculture with stromal cells or in monoculture in the presence of receptor-activated NFkappaB ligand (RANKL) and macrophage colony-stimulating factor. Receptor antagonist studies suggest that isoPGE2 effects were mediated by prostaglandin receptor subtypes EP2/DP on preosteoclasts and subtype EP1 and thromboxane receptors on stromal/osteoblast cells. The enhanced TRAP activity was also inhibited by cAMP-dependent protein kinase inhibitors, and isoPGE2 elevated intracellular cAMP levels of preosteoclast monocultures. Other oxidized lipids also enhanced the TRAP activity of preosteoclast monocultures. These data suggest that isoPGE2 enhances osteoclastic differentiation of marrow preosteoclasts and that this regulation occurs via the cAMP-dependent protein kinase pathway.

    Topics: Actins; Animals; Bone Marrow Cells; Calcitonin; Carrier Proteins; Cell Differentiation; Cell Line; Cells, Cultured; Coculture Techniques; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Isoprostanes; Lipid Metabolism; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microscopy, Phase-Contrast; Osteoclasts; Osteoporosis; Oxygen; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vasoconstrictor Agents

2002
Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:4

    Atherosclerotic calcification and osteoporosis often coexist in patients, yielding formation of bone mineral in vascular walls and its simultaneous loss from bone. To assess the potential role of lipoproteins in both processes, we examined the effects of minimally oxidized low-density lipoprotein (MM-LDL) and several other lipid oxidation products on calcifying vascular cells (CVCs) and bone-derived preosteoblasts MC3T3-E1. In CVCs, MM-LDL but not native LDL inhibited proliferation, caused a dose-dependent increase in alkaline phosphatase activity, which is a marker of osteoblastic differentiation, and induced the formation of extensive areas of calcification. Similar to MM-LDL, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) and the isoprostane 8-iso prostaglandin E2 but not PAPC or isoprostane 8-iso prostaglandin F2 alpha induced alkaline phosphatase activity and differentiation of CVCs. In contrast, MM-LDL and the above oxidized lipids inhibited differentiation of the MC3T3-E1 bone cells, as evidenced by their stimulatory effect on proliferation and their inhibitory effect on the induction of alkaline phosphatase and calcium uptake. These results suggest that specific oxidized lipids may be the common factors underlying the pathogenesis of both atherosclerotic calcification and osteoporosis.

    Topics: Alkaline Phosphatase; Animals; Aorta; Calcinosis; Calcium; Cattle; Cell Differentiation; Cell Division; Cells, Cultured; Dinoprostone; DNA; Isoprostanes; Lipoproteins, LDL; Muscle, Smooth, Vascular; Osteoblasts; Osteoporosis; Oxidation-Reduction

1997